Global Anti-inflammatory Therapeutics Market 2017-2021

  • ID: 4312769
  • Report
  • Region: Global
  • 98 pages
  • TechNavio
1 of 6

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • Boehringer Ingelheim
  • Eli Lilly
  • Johnson & Johnson
  • Novartis
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Inflammation is a part of immune response triggered against harmful stimuli, foreign objects, damaged cells, irritants, and pathogens in the body. The drugs used to treat these symptoms are called anti-inflammatory drugs. It causes the elimination of the initial cause of cell injury, clearance of dead or necrotic cells, and damaged tissue from the site of the inflammatory process and initiates tissue repair.

The report forecasts that the global anti-inflammatory therapeutics market to grow at a CAGR of 6.10% during the period 2017-2021.

Covered in this report:

The report covers the present scenario and the growth prospects of the global anti-inflammatory therapeutics market for 2017-2021. To calculate the market size, the report considers sales of branded, off-label, and generic drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
This report, Global Anti-Inflammatory therapeutics market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

Key vendors:
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
Other prominent vendors:
  • Boehringer Ingelheim
  • Eli Lilly
  • Novartis
Market drivers:
  • Availability of targeted therapy
  • For a full, detailed list, view this report
Market challenges:
  • Complex regulatory approval process for biosimilars
  • For a full, detailed list, view this report
Market trends:
  • Emergence of novel anti-inflammatory drugs
  • For a full, detailed list, view this report
Key questions answered in this report:
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • Boehringer Ingelheim
  • Eli Lilly
  • Johnson & Johnson
  • Novartis
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction
  • Market outline
Part 05: Inflammation: An overview

Part 06: Market landscape
  • Market overview
  • Five forces analysis
Part 07: Key clinical trial

Part 08: Market segmentation by application
  • RA
  • Psoriasis
  • MS
Part 09: Market segmentation by drug class
  • Anti-inflammatory biologicals
  • NSAIDs
  • Corticosteroids
Part 10: Geographical segmentation
  • Anti-inflammatory therapeutics market in Americas
  • Anti-inflammatory therapeutics market in EMEA
  • Anti-inflammatory therapeutics market in APAC
Part 11: Decision framework

Part 12: Drivers and challenges
  • Market drivers
  • Market challenges
Part 13: Market trends
  • Emergence of novel anti-inflammatory drugs
  • Increasing strategic alliances by vendors
  • Advent of biosimilars
Part 14: Vendor landscape
  • Competitive scenario
Part 15: Key vendor analysis
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Other prominent vendors
Part 16: Appendix

List of abbreviations

List of Exhibits
Exhibit 01: Market segmentation of global autoimmune disease market by drug class
Exhibit 02: Snapshot of drivers and challenges present in the market
Exhibit 03: Global anti-inflammatory therapeutics market snapshot
Exhibit 04: Global anti-inflammatory therapeutics market revenue 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global anti-inflammatory therapeutics market
Exhibit 06: Five forces analysis
Exhibit 07: Pipeline snapshot
Exhibit 08: Pipeline landscape
Exhibit 09: Purpose of clinical trial
Exhibit 10: Global anti-inflammatory therapeutics market segmentation based on application
Exhibit 11: Global anti-inflammatory therapeutics market based on application 2016 (%)
Exhibit 12: Risk factors responsible for RA
Exhibit 13: National arthritis prevalence rate in the US 2000-2040
Exhibit 14: Drivers and challenges of global anti-inflammatory RA therapeutics market 2016
Exhibit 15: Global anti-inflammatory RA therapeutics market revenue 2016-2021 ($ millions)
Exhibit 16: Drivers and challenges of global anti-inflammatory psoriasis therapeutics market 2016
Exhibit 17: Global anti-inflammatory psoriasis therapeutics market 2016-2021 ($ millions)
Exhibit 18: Drivers and challenges of global anti-inflammatory MS therapeutics market 2016
Exhibit 19: Global anti-inflammatory MS therapeutics market 2016-2021 ($ millions)
Exhibit 20: Global anti-inflammatory therapeutics market segmentation based on drug class
Exhibit 21: Global anti-inflammatory therapeutics market segmentation based on drug class 2016 (%)
Exhibit 22: Marketed anti-inflammatory biologicals
Exhibit 23: Global anti-inflammatory biologicals therapeutics market 2016-2021 ($ millions)
Exhibit 24: NSAIDs used for the treatment of autoimmune diseases
Exhibit 25: Global anti-inflammatory NSAIDs therapeutics market 2016-2021 ($ millions)
Exhibit 26: Global anti-inflammatory corticosteroid therapeutics market 2016-2021 ($ millions)
Exhibit 27: Global anti-inflammatory therapeutics market based on geography 2016 and 2021 (%)
Exhibit 28: Global anti-inflammatory therapeutics market based on geography 2016-2021 ($ millions)
Exhibit 29: Global anti-inflammatory therapeutics market based on geography 2016-2021 (%)
Exhibit 30: Market scenario in Americas
Exhibit 31: Anti-inflammatory therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 32: Market scenario in EMEA
Exhibit 33: Anti-inflammatory therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 34: Market scenario in APAC
Exhibit 35: Anti-inflammatory therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 36: Prevalence rate of types of IBD in the US 2015
Exhibit 37: Incidence rate of types of IBD in the US 2015
Exhibit 38: Biologics approvals by the US FDA to treat autoimmune diseases
Exhibit 39: Commonly used off-label anti-inflammatory therapeutics
Exhibit 40: Ongoing clinical trials with JAK inhibitors
Exhibit 41: Competitive structure analysis of global anti-inflammatory therapeutics market 2016
Exhibit 42: Competitive landscape snapshot
Exhibit 43: AbbVie: Key highlights
Exhibit 44: AbbVie: Strength assessment
Exhibit 45: AbbVie: Strategy assessment
Exhibit 46: AbbVie: Opportunity assessment
Exhibit 47: Amgen: Key highlights
Exhibit 48: Amgen: Strength assessment
Exhibit 49: Amgen: Strategy assessment
Exhibit 50: Amgen: Opportunity assessment
Exhibit 51: Johnson & Johnson: Key highlights
Exhibit 52: Johnson & Johnson: Strength assessment
Exhibit 53: Johnson & Johnson: Strategy assessment
Exhibit 54: Johnson & Johnson: Opportunity assessment
Exhibit 55: Pfizer: Key highlights
Exhibit 56: Pfizer: Strength assessment
Exhibit 57: Pfizer: Strategy assessment
Exhibit 58: Pfizer: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • AbbVie
  • Amgen
  • Boehringer Ingelheim
  • Eli Lilly
  • Johnson & Johnson
  • Novartis
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

New Research Report - Global Anti-Inflammatory therapeutics market 2017-2021

Other Prominent Vendors in the market are: Boehringer Ingelheim, Eli Lilly, and Novartis.

Commenting on the report, an analyst from the research team said: “One trend in the market is emergence of novel anti-inflammatory drugs. Cytokines are proteins produced by immune cells. These protein molecules facilitate communication between cells and play a pivotal role in cell development and differentiation including regulation of immune response.”

According to the report, one driver in the market is availability of targeted therapy. The global anti-inflammatory therapeutics market is no stranger to biologics. The biologics are macromolecules, consisting of genetically engineered protein derived from living cells. As biologics can be produced by using DNA recombinant technology, they offer targeted therapy and can also be modified depending on patient's need. Owing to their benefits over other small molecules, biologics are dominating the global anti-inflammatory therapeutics market with more than 60% of market share in 2016.

Further, the report states that one challenge in the market is complex regulatory approval process for biosimilars. The Federal Food, Drug, and Cosmetic Act, regulated by the US FDA state that a biosimilar should be highly similar to the reference biologic drug, in terms of safety and efficacy profile. Moreover, the biosimilar drug should be interchangeable with the reference biologic drug without causing any significant difference in the patient and should not require any intervention by the doctor, who prescribes the reference biologic drug.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 6
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • Boehringer Ingelheim
  • Eli Lilly
  • Novartis
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll